Brian L. Durkin - 20 Dec 2021 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role: VP, Controller
Signature: Steven Scrogham, attorney-in-fact for Brian L. Durkin
Issuer symbol: ABBV
Transactions as of: 20 Dec 2021
Net transactions value: -$1,515,133
Form type: 4
Filing time: 21 Dec 2021, 16:29:21 UTC
Next filing: 22 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABBV	Common Stock, $0.01 par value	Options Exercise	$440,565	+7,180	+34%	$61.36	28,295	20 Dec 2021	Direct
transaction	ABBV	Common Stock, $0.01 par value	Sale	$1,515,133	-11,790	-42%	$128.51	16,505	20 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABBV	Option (right to buy)	Options Exercise	$440,565	-7,180	-100%	$61.36	0	20 Dec 2021	Common Stock	7,180	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).